参考文献

1.Stewart FA，Dorr W.Milestones in normal tissue radiation biology over the past 50 years：from clonogenic cell survival to cytokine networks and back to stem cell recovery.Int J Radiat Biol，2009，85 ：574-586.

2.Kerns SL，Ostrer H，Stock R，et al.Genome-wide association study to identify single nucleotide polymorphisms（SNPs） associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.Int J Radiat Oncol Biol Phys，2010，78 ：1292-1300.

3.Mayer C，Popanda O，Greve B，et al.A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects.Cancer Lett，2011，302 ：20-28.

4.Landmark-Hoyvik H，Dumeaux V，Reinertsen KV，et al.Blood gene expression profiling of breast cancer survivors experiencing fibrosis.Int J Radiat Oncol Biol Phys，2011，79 ：875-883.

5.Finnon P，Kabacik S，MacKay A，et al.Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.Radiother.Oncol.，2012，105 ：329-336.

6.Hall EJ，Giaccia AJ.Radiobiology for the Radiologist，seventh ed.，Lippincott Williams & Wilkins，Philadelphia，2012.576 p.

7.Schaue D，Kachikwu EL，McBride WH，et al.Cytokines in radiobiological responses：a review.Radiat.Res，2012，178 ：505-523.

8.Finnon P，Kabacik S，MacKay A，et al.Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.Radiother Oncol，2012，105 ：329-336.

9.Edvardsen H，Landmark-Hoyvik H，Reinertsen KV，et al.SNP in TXNRD2 associated with radiation-induced fibrosis：a study of genetic variation in reactive oxygen species metabolism and signaling.Int J Radiat Oncol Biol Phys，2013，86 ：791-799.

10.Kerns SL，Stock RG，Stone NN，et al.A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.Int J Radiat Oncol Biol Phys，2013，85 ：e21-28.

11.Andreassen CN，Overgaard J，Alsner J.Independent prospective validation of a predictive test for risk of radiation induced fibrosis based on the gene expression pattern in fibroblasts irradiated in vitro.Radiother Oncol，2013，108 ：469-472.

12.Kerns SL，Ostrer H，Rosenstein BS.Radiogenomics：using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Cancer Discov.2014，4 ：155-65.

13.Fachal L，Gomez-Caamano A，Barnett GC，et al.A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.Nat Genet，2014，46 ：891-894.

14.Barnett GC，Thompson D，Fachal L，et al.A genome wide association study（GWAS） providing evidence of an association between common genetic variants and late radiotherapy toxicity.Radiother Oncol，2014，111 ：178-185.

15.Kerns SL，de Ruysscher D，Andreassen CN，et al.STROGAR-STrengthening the Reporting Of Genetic Association studies in Radiogenomics.Radiother Oncol，2014，110 ：182-188.

16.Hatzi VI，Laskaratou DA，Mavragani IV，et al.Non-targeted radiation effects in vivo：a critical glance of the future in radiobiology.Cancer Lett，2015，356 ：34-42.

17.Guo Z，Shu Y，Zhou H，et al.Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Carcinogenesis，2015，36 ：307-317.

18.Clemens E，van der Kooi ALF，Broer L，et al.The influence of genetic variation on late toxicities in childhood cancer survivors：A review.Crit Rev Oncol Hematol，2018，126 ：154-167.